Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Down 6.9% Today

What is Tandem Diabetes Care, Inc.?

Tandem Diabetes Care, Inc. (TNDM) specializes in diabetes management products and technologies within the healthcare and medical devices market, which has seen recent volatility due to regulatory changes and competitive pressures.

Why is Tandem Diabetes Care, Inc. going down?

TNDM stock is down 6.9% on Oct 31, 2025 13:50

• The bearish movement in TNDM's stock today may be linked to the announcement of a securities class action investigation by a law firm. Concerns among investors about potential legal implications possibly triggered a sell-off.
• Despite anticipated outperformance in earnings estimates for the upcoming period, uncertainties related to the investigation might have outweighed any positive outlook, resulting in a negative investor sentiment.
• The current mix of positive earnings expectations and legal concerns has generated a varied sentiment, contributing to a bearish trend for TNDM's stock today.

TNDM Price Chart

TNDM Technical Analysis

TNDM News

Tandem Diabetes Care, Inc. ( TNDM ) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

https://www.zacks.com/stock/news/2781518/tandem-diabetes-care-inc-tndm-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q3-release

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation

New York, New York-- ( Newsfile Corp. - September 25, 2025 ) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. ( NASDAQ: TNDM ) resulting from allegations that Tandem ...

https://markets.businessinsider.com/news/stocks/rosen-global-investor-counsel-encourages-tandem-diabetes-care-inc.-investors-to-inquire-about-securities-class-action-investigation-1035176472

Trending Today

Avantor, Inc. ($AVTR) Stock Forecast: Up 5.4% Today

Western Digital Corporation ($WDC) Stock Forecast: Up 5.5% Today

Regal Beloit Corporation ($RBC) Stock Forecast: Up 5.0% Today

Starbucks Corporation ($SBUX) Stock Forecast: Down 5.1% Today

CleanSpark Inc ($CLSK) Stock Forecast: Down 5.2% Today

Roku Inc. ($ROKU) Stock Forecast: Up 6.4% Today

Riot Platforms, Inc. ($RIOT) Stock Forecast: Down 7.7% Today

DXC Technology Company ($DXC) Stock Forecast: Up 5.8% Today

Illumina Inc. ($ILMN) Stock Forecast: Up 23.9% Today

First Solar Inc. ($FSLR) Stock Forecast: Up 10.8% Today

Tandem Diabetes Care, Inc. Price History

07.07.2025 - TNDM Stock was down 20.7%

• Tandem Diabetes Care (TNDM) reported a Q2 loss of $0.78, missing the estimated $0.40, leading to a significant drop in the stock price.
• The stock also suffered due to guidance cuts and device recalls, with adverse events and injuries linked to malfunctioning insulin pumps triggering a correction.
• Despite the bearish movement, some analysts are optimistic about TNDM, pointing to technical chart patterns like the formation of a hammer chart and positive revisions in earnings estimates as reasons to consider it a 'buy' opportunity.

07.07.2025 - TNDM Stock was down 28.7%

• TNDM exceeded revenue expectations but reported a loss in Q2, potentially influencing the bearish trend.
• A hammer chart formation and positive adjustments in earnings forecasts from financial analysts hint at a possible turnaround for TNDM, suggesting a chance for investment.
• Investor wariness following the company's recent loss may be contributing to the stock's downward movement.
• Mixed signals from the earnings report and technical chart pattern may be causing uncertainty among investors, leading to TNDM's current downward trajectory.

11.07.2025 - TNDM Stock was down 5.1%

• TNDM stock saw a significant decline after its Q2 earnings announcement, despite surpassing revenue expectations and boosting gross margin. The drop was a result of missed earnings and reduced guidance, leading to a 20% decrease in share price.
• Concerns about device recalls and malfunctions added to the stock's plunge, with a considerable number of adverse incidents and injuries reported. This raised apprehensions among investors regarding the quality and safety standards of the company's products.
• Despite the bearish trend, some experts suggest that TNDM might be approaching a support level, as evidenced by a hammer chart formation. Moreover, the consensus among financial analysts in increasing earnings projections could hint at a buying opportunity for investors interested in the company's long-term potential.

09.06.2025 - TNDM Stock was down 5.1%

• TNDM likely experienced a bearish movement due to overall market sentiment affecting investor confidence.
• The downbeat sales reported by Aehr Test Systems may have contributed to a negative investor outlook on the sector, leading to a ripple effect on TNDM.
• Investors may have reacted to the worse-than-expected sales results, causing a shift towards more cautious trading strategies and selling off positions in companies like TNDM.
• The mixed stock movements in the pre-market session could have added to the uncertainty, prompting investors to take a more risk-averse approach and sell off shares in TNDM.

10.09.2025 - TNDM Stock was down 5.2%

• A securities class action investigation could have raised concerns among investors, leading to a sell-off of TNDM shares.
• Investor uncertainty regarding the potential outcomes of the investigation might have contributed to the bearish movement in TNDM stock.
• The negative sentiment surrounding the company due to the ongoing legal scrutiny could have overshadowed any positive developments, impacting the stock price negatively.

31.09.2025 - TNDM Stock was down 6.9%

• The bearish movement in TNDM's stock today may be linked to the announcement of a securities class action investigation by a law firm. Concerns among investors about potential legal implications possibly triggered a sell-off.
• Despite anticipated outperformance in earnings estimates for the upcoming period, uncertainties related to the investigation might have outweighed any positive outlook, resulting in a negative investor sentiment.
• The current mix of positive earnings expectations and legal concerns has generated a varied sentiment, contributing to a bearish trend for TNDM's stock today.

30.04.2025 - TNDM Stock was down 5.2%

• The recent earnings report for TNDM was positive, with the stock price increasing by 6.5% since the last report.
• Despite the positive earnings, the market might have reacted bearishly due to profit-taking by investors who saw the recent gains as an opportunity to sell.
• Investors may also be concerned about future growth prospects or external factors impacting the company's performance, leading to the bearish movement today.
• Monitoring upcoming news and developments related to TNDM is important to better understand market sentiment and potential future movements.

31.06.2025 - TNDM Stock was down 5.0%

• The bearish movement in TNDM stock today could be due to profit-taking by investors who were anticipating a positive earnings report.
• Despite expectations of beating earnings estimates, market conditions or external factors might have influenced the stock's downward movement.
• Investors may have reacted negatively to any unexpected news or developments within the company that were not captured in the earnings expectations.
• It's possible that market sentiment shifted, leading to a sell-off in TNDM shares despite the positive outlook for earnings.

17.08.2025 - TNDM Stock was down 2.7%

• An investigation into potential securities claims on behalf of Tandem Diabetes Care shareholders may have raised concerns and uncertainty among investors, contributing to a bearish movement in the stock.
• An endorsement of Tandem Diabetes Care as a speculative stock for younger investors could have added volatility to the stock, attracting both buyers and sellers and contributing to the bearish trend.
• A contrasting recommendation to buy other stocks like Cintas (NASDAQ: CTAS) and Intuitive Surgical (NASDAQ: ISRG) might have diverted attention and capital away from Tandem Diabetes Care, impacting its stock performance negatively.

06.07.2025 - TNDM Stock was down 5.0%

• Despite recent losses, TNDM seems to have found support indicated by a hammer chart pattern, suggesting a potential reversal in the stock's movement.
• Wall Street analysts are showing strong agreement in revising earnings estimates higher for TNDM, indicating confidence in the stock's potential.
• The bullish sentiment from analysts combined with the technical chart pattern could be signaling a buying opportunity for investors looking to capitalize on the potential turnaround in TNDM's stock price.

22.06.2025 - TNDM Stock was up 5.2%

• TNDM observed a noteworthy upward movement today, potentially influenced by investors interpreting the recent selling pressure as a buying opportunity.
• The technical analysis indicating TNDM being in oversold territory might have attracted value investors on the lookout for a possible stock price recovery.
• The consensus among financial analysts raising earnings estimates for TNDM might have also played a role in fostering positive sentiment, hinting at a potential uptick in the stock's performance.
• In summary, the amalgamation of technical indicators and analyst outlook may have been key drivers behind the positive movement in TNDM today, as investors aimed to benefit from what they viewed as an undervalued stock.

01.09.2025 - TNDM Stock was up 7.7%

• Initial uncertainty and bearish sentiment among investors may have been influenced by an ongoing securities fraud investigation.
• If the investigation results do not substantially impact the company, investors may become more confident in Tandem's future prospects, potentially contributing to the bullish movement.
• Market participants seem to view the news positively, indicating that Tandem's financial health and operations may not be significantly impacted by the investigation, resulting in the stock price rise.